Association of genetic polymorphisms in the telomerase reverse transcriptase gene with prostate cancer aggressiveness

Wu,Dapeng; Yu,Hongjie; Sun,Jielin; Qi,Jun; Liu,Qiang; Li,Ruipeng; Zheng,Siqun Lily; Xu,Jianfeng; Kang,Jian

doi:10.3892/mmr.2015.3410

Association of genetic polymorphisms in the telomerase reverse transcriptase gene with prostate cancer aggressiveness

Authors:
- Dapeng Wu
- Hongjie Yu
- Jielin Sun
- Jun Qi
- Qiang Liu
- Ruipeng Li
- Siqun Lily Zheng
- Jianfeng Xu
- Jian Kang
View Affiliations

Affiliations: Department of Urology, Xinhua Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 200092, P.R. China, State Key Laboratory of Genetic Engineering, School of Life Sciences, Fudan University, Shanghai 200433, P.R. China, Center for Cancer Genomics, Wake Forest University School of Medicine, Winston‑Salem, NC 27157, USA
Published online on: March 4, 2015 https://doi.org/10.3892/mmr.2015.3410
Pages: 489-497

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Telomerase reverse transcriptase (TERT), encoded by the TERT gene, is an essential component of telomerase, essential for the maintenance of telomere DNA length, chromosomal stability and cellular immortality. The aim of the present study was to evaluate the association between common genetic variations across the TERT gene region and prostate cancer (PCa) aggressiveness in a Chinese population. A total of 12 TERT tagging single‑nucleotide polymorphisms (SNPs) were genotyped on the Sequenom Mass‑ARRAY iPLEX® platform in a case‑case study with 1,210 Chinese patients with PCa. Unconditional logistic regression was used to investigate the association of genotypes with PCa aggressiveness, Gleason grade and risk of developing early‑onset PCa. It was observed that the C allele of the TERT intron 2 SNP (rs2736100) was significantly associated with reduced risk of PCa aggressiveness [odds ratio (OR)=0.81; 95% confidence interval (CI): 0.66‑0.99; P=0.037]. This allele was also significantly correlated with a reduced risk of developing a tumor with a high Gleason score (>7; OR=0.83; 95% CI: 0.70‑0.99; P=0.039). The T allele of the intron 4 SNP (rs10069690) was found to be significantly associated with a decreased risk for an aggressive form of PCa (OR=0.76; 95% CI: 0.59‑0.97; P=0.030). In addition, the A allele of rs10078761 located at the 3' end of the TERT gene exhibited a statistically significant association with the reduced risk of developing a higher grade disease (OR=0.48; 95% CI: 0.28‑0.81; P=0.006). However, no association between TERT polymorphisms and age at diagnosis was observed in the present study. The present findings demonstrated for the first time, to the best of our knowledge, that genetic variations across the TERT gene are associated with PCa aggressiveness in a Chinese Han population.

View Figures

View References

1	Shay J and Bacchetti S: A survey of telomerase activity in human cancer. Eur J Cancer. 33:787–791. 1997. View Article : Google Scholar : PubMed/NCBI
2	Mocellin S, Verdi D, Pooley KA, et al: Telomerase reverse transcriptase locus polymorphisms and cancer risk: a field synopsis and meta-analysis. J Natl Cancer Instit. 104:840–854. 2012. View Article : Google Scholar
3	Harley CB: Telomerase and cancer therapeutics. Nat Rev Cancer. 8:167–179. 2008. View Article : Google Scholar : PubMed/NCBI
4	Horikawa I and Barrett JC: Transcriptional regulation of the telomerase hTERT gene as a target for cellular and viral oncogenic mechanisms. Carcinogenesis. 24:1167–1176. 2003. View Article : Google Scholar : PubMed/NCBI
5	Nandakumar J and Cech TR: Finding the end: recruitment of telomerase to telomeres. Nat Rev Mol Cell Biol. 14:69–82. 2013. View Article : Google Scholar : PubMed/NCBI
6	Baird DM: Variation at the TERT locus and predisposition for cancer. Expert Rev Mol Med. 12:1–21. 2010. View Article : Google Scholar
7	Rafnar T, Sulem P, Stacey SN, et al: Sequence variants at the TERT-CLPTM1 L locus associate with many cancer types. Nat Genet. 41:221–227. 2009. View Article : Google Scholar : PubMed/NCBI
8	Siegel R, Ma J, Zou Z and Jemal A: Cancer statistics, 2014. CA Cancer J Clin. 64:9–29. 2014. View Article : Google Scholar : PubMed/NCBI
9	March-Villalba JA, Martínez-Jabaloyas JM, Herrero MJ, Santamaría J, Aliño SF and Dasí F: Plasma hTERT mRNA discriminates between clinically localized and locally advanced disease and is a predictor of recurrence in prostate cancer patients. Expert Opin Biol Ther. 12:69–77. 2012. View Article : Google Scholar
10	Heijnsdijk E, Der Kinderen A, Wever E, Draisma G, Roobol M and De Koning H: Overdetection, overtreatment and costs in prostate-specific antigen screening for prostate cancer. Br J Cancer. 101:1833–1838. 2009. View Article : Google Scholar : PubMed/NCBI
11	Cheng I, Plummer SJ, Neslund-Dudas C, et al: Prostate cancer susceptibility variants confer increased risk of disease progression. Cancer Epidemiol Biomarkers Prev. 19:2124–2132. 2010. View Article : Google Scholar : PubMed/NCBI
12	FitzGerald LM, Kwon EM, Conomos MP, et al: Genome-wide association study identifies a genetic variant associated with risk for more aggressive prostate cancer. Cancer Epidemiol Biomarkers Prev. 20:1196–1203. 2011. View Article : Google Scholar : PubMed/NCBI
13	Sabaliauskaite R, Jarmalaite S, Petroska D, et al: Combined analysis of TMPRSS2-ERG and TERT for improved prognosis of biochemical recurrence in prostate cancer. Gene Chromosome Canc. 51:781–791. 2012. View Article : Google Scholar
14	Iczkowski KA, Pantazis CG, McGregor DH, Wu Y and Tawfik OW: Telomerase reverse transcriptase subunit immunoreactivity. Cancer. 95:2487–2493. 2002. View Article : Google Scholar : PubMed/NCBI
15	Gleason DF and Mellinger GT: Prediction of prognosis for prostatic adenocarcinoma by combined histological grading and clinical staging. J Urol. 111:58–64. 1974.PubMed/NCBI
16	D’Amico AV, Whittington R, Malkowicz SB, et al: Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. JAMA. 280:969–974. 1998. View Article : Google Scholar
17	Purcell S, Neale B, Todd-Brown K, et al: PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Gen. 81:559–575. 2007. View Article : Google Scholar
18	Witte JS: Prostate cancer genomics: towards a new understanding. Nat Reviews Genet. 10:77–82. 2009. View Article : Google Scholar
19	Wick M, Zubov D and Hagen G: Genomic organization and promoter characterization of the gene encoding the human telomerase reverse transcriptase (hTERT). Gene. 232:97–106. 1999. View Article : Google Scholar : PubMed/NCBI
20	Wang S, Wu J, Hu L, et al: Common genetic variants in TERT contribute to risk of cervical cancer in a Chinese population. Mol Carcinog. 51:E118–E122. 2012. View Article : Google Scholar : PubMed/NCBI
21	Kumar-Sinha C, Tomlins SA and Chinnaiyan AM: Recurrent gene fusions in prostate cancer. Nat Rev Cancer. 8:497–511. 2008. View Article : Google Scholar : PubMed/NCBI
22	Landi MT, Chatterjee N, Yu K, et al: A genome-wide association study of lung cancer identifies a region of chromosome 5p15 associated with risk for adenocarcinoma. Am J Hum Gene. 85:679–691. 2009. View Article : Google Scholar
23	Taylor J, Tyekucheva S, King DC, Hardison RC, Miller W and Chiaromonte F: ESPERR: learning strong and weak signals in genomic sequence alignments to identify functional elements. Genome Res. 16:1596–1604. 2006. View Article : Google Scholar : PubMed/NCBI
24	Sheng X, Tong N, Tao G, et al: TERT polymorphisms modify the risk of acute lymphoblastic leukemia in Chinese children. Carcinogenesis. 34:228–235. 2013. View Article : Google Scholar
25	Willeit P, Willeit J, Mayr A, et al: Telomere length and risk of incident cancer and cancer mortality. JAMA. 304:69–75. 2010. View Article : Google Scholar : PubMed/NCBI
26	Feldser DM, Hackett JA and Greider CW: Telomere dysfunction and the initiation of genome instability. Nat Rev Cancer. 3:623–627. 2003. View Article : Google Scholar : PubMed/NCBI
27	Mirabello L, Huang WY, Wong JY, et al: The association between leukocyte telomere length and cigarette smoking, dietary and physical variables and risk of prostate cancer. Aging cell. 8:405–413. 2009. View Article : Google Scholar : PubMed/NCBI
28	Ma H, Zhou Z, Wei S, et al: Shortened telomere length is associated with increased risk of cancer: a meta-analysis. PLoS One. 6:e204662011. View Article : Google Scholar : PubMed/NCBI
29	Dong J, Wang L, Tian Y, Guo Y and Liu H: hTERT single nucleotide polymorphism is associated with increased risks of hepatocellular carcinoma and tumor metastasis. Nan Fang Yi Ke Da Xue Xue Bao. 31:49–52. 2011.In Chinese. PubMed/NCBI
30	Bensen JT, Xu Z, Smith GJ, Mohler JL, Fontham ET and Taylor JA: Genetic polymorphism and prostate cancer aggressiveness: A case-only study of 1,536 GWAS and candidate SNPs in African-Americans and European-Americans. Prostate. 73:11–22. 2013. View Article : Google Scholar